首页> 美国卫生研究院文献>American Journal of Public Hygiene >The Mother of All Pandemics Is 100 Years Old (and Going Strong)!
【2h】

The Mother of All Pandemics Is 100 Years Old (and Going Strong)!

机译:所有大流行病的母亲都有100岁的年龄(并且要坚强起来)!

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This year marks the 100th anniversary of the deadliest event in human history. In 1918–1919, pandemic influenza appeared nearly simultaneously around the globe and caused extraordinary mortality (an estimated 50–100 million deaths) associated with unexpected clinical and epidemiological features. The descendants of the 1918 virus remain today; as endemic influenza viruses, they cause significant mortality each year.Although the ability to predict influenza pandemics remains no better than it was a century ago, numerous scientific advances provide an important head start in limiting severe disease and death from both current and future influenza viruses: identification and substantial characterization of the natural history and pathogenesis of the 1918 causative virus itself, as well as hundreds of its viral descendants; development of moderately effective vaccines; improved diagnosis and treatment of influenza-associated pneumonia; and effective prevention and control measures.Remaining challenges include development of vaccines eliciting significantly broader protection (against antigenically different influenza viruses) that can prevent or significantly downregulate viral replication; more complete characterization of natural history and pathogenesis emphasizing the protective role of mucosal immunity; and biomarkers of impending influenza-associated pneumonia.
机译:今年是人类历史上最致命事件的100周年。在1918-1919年间,大流行性流感在全球几乎同时出现,并导致异常的死亡(估计有50-1亿人死亡),并伴有意外的临床和流行病学特征。 1918年病毒的后代至今仍保留着。尽管作为流行性感冒病毒,它们每年都会导致巨大的死亡率。尽管预测流行性感冒的能力仍然不比一个世纪前强,但许多科学进展为限制当前和未来流行性感冒病毒的严重疾病和死亡提供了重要的开端。 :对1918年致病病毒本身及其数百个病毒后代的自然历史和发病机理的鉴定和实质性表征;开发中度有效的疫苗;改善与流感有关的肺炎的诊断和治疗;仍然存在的挑战包括开发能够显着扩大保护范围的疫苗(针对抗原性不同的流感病毒),从而可以预防或显着下调病毒复制。自然史和发病机制的更完整表征,强调粘膜免疫的保护作用;以及即将与流感相关的肺炎的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号